Empresa Immutep Ltd Australian S.E.
Acciones
AU000000PRR9
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Marc Voigt
CEO | Chief Executive Officer | 51 | 01/01/11 |
David Fang
DFI | Director of Finance/CFO | - | 01/03/18 |
Florian Vogl
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/23 |
Deanne Miller
COO | Chief Operating Officer | 47 | 17/10/12 |
Frédéric Triebel
CTO | Chief Tech/Sci/R&D Officer | 69 | 12/12/14 |
Claudia Jacoby
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - | |
Frank Fliegert
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 01/01/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Russell Howard
CHM | Chairman | 74 | 08/05/13 |
Marc Voigt
CEO | Chief Executive Officer | 51 | 01/01/11 |
Anne Anderson
BRD | Director/Board Member | - | 14/02 |
Frédéric Triebel
CTO | Chief Tech/Sci/R&D Officer | 69 | 12/12/14 |
Pete Meyers
BRD | Director/Board Member | 55 | 12/02/14 |
Lis Boyce
BRD | Director/Board Member | - | 11/04/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 1 263 136 719 | 1 224 288 891 ( 96,92 %) | 0 | 96,92 % |
Información de la empresa
![Dirección Immutep Ltd](https://cdn.zonebourse.com/static/address/6500491.png)
Empresas del grupo
Nombre | Categoría y sector |
---|---|
Immutep GmbH
![]() Immutep GmbH BiotechnologyHealth Technology Part of Immutep Ltd., Immutep GmbH develops novel immunotherapy treatments for cancer and autoimmune disease. The company is based in Leipzig, Germany. The CEOs of the German company are - Kaufmann, Marc Voigt, Deanne Miller. |
Biotechnology
|
Sector
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
+19,41 % | 45,51 mil M | |
-8,62 % | 38,52 mil M | |
+38,45 % | 38,13 mil M | |
+26,95 % | 30,74 mil M | |
-13,50 % | 26,03 mil M | |
+10,74 % | 25,92 mil M | |
+44,87 % | 14,13 mil M | |
+34,36 % | 12,73 mil M | |
-7,14 % | 11,29 mil M |